These results are consistent with those reported by Seth et al. [14] and Zińczuk et al. [15], who found that the levels of serum SOD (p < 0.0001) and CAT (p < 0.0001) were significantly increased in breast cancer patients as compared to controls. Here, SOD1 is linked to breast carcinoma.